Pay in 4 interest-free payments of $6.75 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Semaglutide is a GLP-1 medication that reduces appetite, while AOD 9604 is a growth hormone fragment studied for fat metabolism
The peptide addresses connective tissue conditions (tendonitis and ligament ruptures) by accelerating structural repair at the cellular level
[75:52] Andrew Huberman I'll say this
Evaluation of: Glycerol production (a marker of lipolysis) 2-deoxyglucose uptake (a marker of insulin signaling) DNA synthesis (a marker of proliferation) What they found: AOD-9604 stimulated lipolysis dose-dependently from 10 M, with a plateau at 10 M Full hGH stimulated lipolysis to a similar maximum, but with different kinetics AOD-9604 did not affect glucose uptake or DNA synthesis at all, whereas hGH inhibited both (the classic lipotoxic GH effect) Fragments with different sequence (from the N-terminal part of hGH) had no lipolytic effect Why it matters: This was the first publication of AOD-9604
US$ 22.28
US$ 24.87
US$ 24.69
US$ 28.84
US$ 27.64
US$ 25.75